JAMP Pharma Corporation is recalling its digoxin tablets because some bottles may contain an incorrect dose, Health Canada announced in an advisory. The drug-maker said its 0.0625 and 0.125 mg ...

Digoxin tablet: The 125- and 250-microgram digoxin tablets have been discontinued. This cardiac medication is no longer available due to business reasons as of December 2024. Edaravone injection ...

Aims In the Digitalis Investigation Group (DIG) trial, digoxin reduced mortality or hospitalization due to heart failure (HF) in several pre-specified high-risk subgroups of HF patients ...

See Contraindications. QT prolongation with concomitant dofetilide, quinidine, pimozide, cisapride, methadone, disopyramide, dronedarone, ranolazine. Concomitant ...

Digoxin is used extensively in combination with other medications in the treatment of heart failure, and is often prescribed to patients with atrial fibrillation — a kind of irregular heartbeat ...

Increased intraocular pressure with concomitant corticosteroids. May potentiate slow-dissolving digoxin tablets; use rapidly-dissolving digoxin tablets instead. Drying of salivary secretions ...

In the third study, blood samples for the analysis of digoxin concentrations were obtained before digoxin administration on days 9-15 and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 18, and 24 hours after ...